文献速递认知障碍与痴呆

老年唐氏综合征成人中衰老、痴呆与多病共存的患病率

Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.
PubMed 文献 · JAMA Neurol · 2018-01-01

基于2015年加州医疗保险索赔数据的横断面分析,878例45岁及以上唐氏综合征成人中40%被诊断痴呆,65岁及以上升至49%;痴呆者共病数多于无痴呆者(平均3.4 vs 2.5),甲状腺功能减退、癫痫、贫血和体重减轻在痴呆者中更常见。

要点

  • 唐氏综合征成人痴呆诊断率40%,65岁及以上升至49%。
  • 痴呆者平均共病数3.4,无痴呆者2.5,65岁以下差异更明显。
  • 甲状腺功能减退、癫痫、贫血、体重减轻在痴呆者中更常见。

核心结论

  • 加州老年唐氏综合征医保受益人,尤其痴呆者,多病共存水平高,包括数种可治疗疾病。
  • 唐氏综合征随访长期局限于儿科,长寿将需要复杂的成人及老年医疗照护。
  • 更多循证且标准化的随访可能有助于改善老年唐氏综合征成人的长期共病管理和痴呆照护。

研究设计与样本

  • 2015年加州医疗保险索赔数据的横断面分析。
  • 纳入2015年同时参加Medicare Part A和B的全部加州医保受益人,45岁及以上共3 001 977人,其中878人诊断为唐氏综合征。
  • 数据分析时间为2017年4月至2018年2月。

主要发现

  • 878例唐氏综合征成人中353例(40%)被诊断痴呆(平均58.7岁;女性173例[49%]),525例无痴呆诊断(平均55.9岁;女性250例[48%])。
  • 65岁及以上唐氏综合征者痴呆频率升至49%。
  • 人均共病数随年龄总体增加;痴呆者共病数多于无痴呆者(平均3.4 vs 2.5),65岁以下人群差异尤其明显。
  • 甲状腺功能减退、癫痫、贫血和体重减轻4种可治疗疾病在唐氏综合征痴呆者中更常见。

临床怎么用

  • 作者认为,唐氏综合征患者的长寿将需要复杂的成人及老年医疗照护。
  • 作者认为,更多循证且标准化的随访可能有助于支持老年唐氏综合征成人更好的长期共病管理和痴呆照护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: As the life expectancy of people with Down syndrome (DS) has markedly increased over the past decades, older adults with DS may be experiencing a higher incidence of aging conditions. In addition to longevity, the amyloid precursor protein gene located on chromosome 21 places individuals with DS at a high risk for developing Alzheimer disease. Yet, few studies have determined prevalence of dementia and comorbidities among older people with DS. OBJECTIVE: To determine the prevalence of dementia and aging-related comorbidities in older adult individuals with DS. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analysis of 2015 California Medicare claims data. We examined 1 year of cross-sectional Medicare claims data that included 100% of Californian Medicare beneficiaries enrolled in both Medicare Part A and B in 2015. Of these 3 001 977 Californian Medicare beneficiaries 45 years or older, 878 individuals were identified as having a diagnosis of DS. Data were analyzed between April 2017 and February 2018. MAIN OUTCOMES AND MEASURES: The frequency of DS dementia was assessed across different age categories. The number and frequency of 27 comorbidities were compared among individuals with DS with and without dementia and by age and sex groups. RESULTS: A total of 353 DS individuals (40%) were identified as having dementia diagnoses (mean, 58.7 years; 173 women [49%]) and 525 without dementia diagnoses (mean, 55.9 years; 250 women [48%]). The frequency of DS dementia among those 65 years or older rose to 49%. The mean number of comorbidities per individual increased with age in general. Comorbid conditions were more numerous among those with dementia compared with those with DS without dementia (mean, 3.4 vs 2.5, respectively), especially among those younger than 65 years. In particular, 4 treatable conditions, hypothyroidism, epilepsy, anemia, and weight loss, were much more frequent in DS dementia. CONCLUSIONS AND RELEVANCE: Older Medicare beneficiaries in California with DS, especially those with dementia, have a high level of multimorbidity including several treatable conditions. While DS follow-up has long been confined to the pediatric sphere, we found that longevity in individuals with DS will necessitate complex adult and geriatric care. More evidenced-based and standardized follow-up could support better long-term comorbidity management and dementia care among aging adults with DS.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Bayen E, Possin KL, Chen Y, et al. Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome. JAMA Neurol. 2018. PMID: 30032260. doi:10.1001/jamaneurol.2018.2210

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。